L Romics

823 total citations
42 papers, 587 citations indexed

About

L Romics is a scholar working on Surgery, Epidemiology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, L Romics has authored 42 papers receiving a total of 587 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Surgery, 8 papers in Epidemiology and 8 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in L Romics's work include Lipoproteins and Cardiovascular Health (13 papers), Cancer, Lipids, and Metabolism (7 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (5 papers). L Romics is often cited by papers focused on Lipoproteins and Cardiovascular Health (13 papers), Cancer, Lipids, and Metabolism (7 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (5 papers). L Romics collaborates with scholars based in Hungary, United States and Netherlands. L Romics's co-authors include István Karádi, Zoltán Prohászka, Mahavir Singh, George Füst, B. Fekete, Jack Doman, Gerhard M. Kostner, Albert Császár, László Jakab and Csaba Szalai and has published in prestigious journals such as The Lancet, Diabetologia and Clinical Chemistry.

In The Last Decade

L Romics

37 papers receiving 563 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
L Romics Hungary 13 198 151 147 125 97 42 587
Danuta Fedak Poland 15 108 0.5× 84 0.6× 140 1.0× 84 0.7× 101 1.0× 43 615
P. B. B. Jones New Zealand 14 99 0.5× 159 1.1× 174 1.2× 35 0.3× 92 0.9× 21 724
Gert‐Jan M. van de Geijn Netherlands 16 174 0.9× 129 0.9× 162 1.1× 52 0.4× 85 0.9× 24 691
Lili Magyari Hungary 14 110 0.6× 237 1.6× 105 0.7× 68 0.5× 67 0.7× 40 607
Changjie Song Australia 10 165 0.8× 180 1.2× 318 2.2× 46 0.4× 53 0.5× 14 620
Jan Willem F. Elte Netherlands 9 267 1.3× 70 0.5× 83 0.6× 317 2.5× 101 1.0× 12 642
Abdalrahman Zarzour United States 9 104 0.5× 167 1.1× 160 1.1× 44 0.4× 75 0.8× 11 505
Yasuhito Suzuki Japan 13 47 0.2× 89 0.6× 155 1.1× 71 0.6× 47 0.5× 46 627
Rachel Caron United States 6 112 0.6× 323 2.1× 144 1.0× 78 0.6× 288 3.0× 9 875
Jerzy Bodalski Poland 15 165 0.8× 87 0.6× 177 1.2× 160 1.3× 37 0.4× 64 798

Countries citing papers authored by L Romics

Since Specialization
Citations

This map shows the geographic impact of L Romics's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L Romics with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L Romics more than expected).

Fields of papers citing papers by L Romics

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L Romics. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L Romics. The network helps show where L Romics may publish in the future.

Co-authorship network of co-authors of L Romics

This figure shows the co-authorship network connecting the top 25 collaborators of L Romics. A scholar is included among the top collaborators of L Romics based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L Romics. L Romics is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Romics, L, et al.. (2009). Effect of Growth Hormone on Serum Lipoproteins in Growth Hormone Deficiency. Experimental and Clinical Endocrinology & Diabetes. 90(5). 227–231.
2.
Förhécz, Zsolt, Nóra Hosszúfalusi, Szilvia Walentin, et al.. (2005). High levels of C‐reactive protein with low total cholesterol concentrations additively predict all‐cause mortality in patients with coronary artery disease. European Journal of Clinical Investigation. 35(2). 104–111. 8 indexed citations
3.
Huszti, Z., et al.. (2004). Low levels of antibodies against E. coli and mycobacterial 65kDa heat shock proteins in patients with inflammatory bowel disease. Inflammation Research. 53(10). 551–555. 10 indexed citations
4.
Vatay, Ágnes, Yan Yang, Erwin K. Chung, et al.. (2003). Relationship between complement components C4A and C4B diversities and two TNFA promoter polymorphisms in two healthy Caucasian populations. Human Immunology. 64(5). 543–552. 12 indexed citations
5.
6.
Komlósi, Katalin, Judit Bene, Manju Ghosh, et al.. (2003). Search for Factor V Arg<sup>306</sup> Cambridge and Hong Kong Mutations in Mixed Hungarian Population Samples. Acta Haematologica. 110(4). 220–222. 2 indexed citations
7.
Szamosi, Tamás, Mahavir Singh, István Karádi, et al.. (2002). Complement activating antibodies against the human 60 kDa heat shock protein as a new independent family risk factor of coronary heart disease. European Journal of Clinical Investigation. 32(6). 405–410. 19 indexed citations
8.
Czirják, László, B. Fekete, László Jakab, et al.. (2001). Levels of antibodies against C1q and 60 kDa family of heat shock proteins in the sera of patients with various autoimmune diseases. Immunology Letters. 75(2). 103–109. 32 indexed citations
9.
Prohászka, Zoltán, J. Duba, Albert Császár, et al.. (2001). Comparative study on antibodies to human and bacterial 60 kDa heat shock proteins in a large cohort of patients with coronary heart disease and healthy subjects. European Journal of Clinical Investigation. 31(4). 285–292. 60 indexed citations
10.
Karádi, István, et al.. (1999). Determination of human serum semicarbazide-sensitive amine oxidase activity: a possible clinical marker of atherosclerosis. European Journal of Drug Metabolism and Pharmacokinetics. 24(4). 299–302. 28 indexed citations
11.
Fintor, L., et al.. (1999). Distribution of apolipoprotein(a) isoforms in normotensive and severe preeclamptic women. The Journal of Maternal-Fetal Medicine. 8(6). 270–274. 13 indexed citations
12.
Császár, Albert, et al.. (1995). High lipoprotein(a) levels with predominance of high molecular weight apo(a) isoforms in patients with pulmonary embolism. European Journal of Clinical Investigation. 25(5). 368–370. 14 indexed citations
13.
Tonstad, Serena, R. F. Bing, J. Fröhlich, et al.. (1995). Effectiveness of Colestipol Tablets vs Granules in Patients with Moderate to Severe Hypercholesterolaemia. Clinical Drug Investigation. 10(5). 257–263. 3 indexed citations
14.
Dieplinger, Hans, C. Sandholzer, Heinz Drexel, et al.. (1993). Plasma lipoprotein(a) concentration and phenotypes in diabetes mellitus. Diabetologia. 36(1). 47–51. 57 indexed citations
15.
Romics, L, Lajos Szollár, & G Zajkás. (1993). [Management of arteriosclerosis-related lipid metabolism disorders. Recommendations of the Hungarian Lipid Consensus Conference].. PubMed. 134(5). 227–38. 7 indexed citations
16.
Császár, Albert, et al.. (1991). [Distribution of apolipoprotein A I and B in the blood according to age and gender, as well as their relation to blood cholesterol levels in the Hungarian blood donor population].. PubMed. 132(33). 1795–800. 1 indexed citations
17.
Romics, L, et al.. (1988). Sex- and age-dependence of platelet aggregation in diabetes mellitus.. PubMed. 45(1). 115–25. 2 indexed citations
18.
Romics, L, et al.. (1982). Effect of metabolic control of the serum lipid and lipoprotein levels on insulin-dependent diabetes mellitus.. PubMed. 39(3-4). 117–23. 2 indexed citations
19.
Romics, L, et al.. (1978). [Roentgen anatomy of and serum lipids in the coronary vessels in ischemic heart disease].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 119(15). 895–7.
20.
Romics, L, et al.. (1969). MEASUREMENT OF GLOMERULAR FILTRATION-RATE. The Lancet. 293(7588). 261–261. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026